Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mutations01:39

Mutations

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and monitoring of in vitro formation of salicylic acid from aspirin using fluorescence spectroscopic technique and DFT calculations.

Journal of photochemistry and photobiology. B, Biology·2018
Same author

Scavenging of hydroxyl, methoxy, and nitrogen dioxide free radicals by some methylated isoflavones.

Journal of molecular modeling·2018
Same author

Detection of in Vitro Metabolite Formation of Leflunomide: A Fluorescence Dynamics and Electronic Structure Study.

Journal of medicinal chemistry·2016
Same author

Modeling the scavenging activity of ellagic acid and its methyl derivatives towards hydroxyl, methoxy, and nitrogen dioxide radicals.

Journal of molecular modeling·2013
Same author

Urocanic acid as an efficient hydroxyl radical scavenger: a quantum theoretical study.

Journal of molecular modeling·2010
Same author

A quantum chemical study of repair of O6-methylguanine to guanine by tyrosine: evaluation of the winged helix-turn-helix model.

Journal of molecular modeling·2009

Related Experiment Video

Updated: May 8, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Is FapyG mutagenic?: Evidence from the DFT study.

Nihar Ranjan Jena1, Phool Chand Mishra

  • 1Discipline of Natural Sciences, Indian Institute of Information Technology, Design and Manufacturing, Khamaria, Jabalpur-482005 (India); Current address School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane QLD 4072 (Australia). nrjena@iiitdmj.ac.in.

Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|August 13, 2013
PubMed
Summary

2,6-diamino-4-oxo-5-formamidopyrimidine (FapyG), an oxidized guanine product, is non-mutagenic in bacteria but causes G to T mutations in mammals. This study explains FapyG

Keywords:
DNA damagecancerdensity functional calculationsmuagenesisnucleobases

More Related Videos

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

Related Experiment Videos

Last Updated: May 8, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • 2,6-diamino-4-oxo-5-formamidopyrimidine (FapyG) is a major oxidative guanine (G) lesion.
  • FapyG is considered non-mutagenic in bacteria but mutagenic in mammalian cells, causing G to T mutations.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying FapyG's differential mutagenicity in bacterial versus mammalian cells.
  • To investigate the base-pairing properties of FapyG with DNA bases (C, A, T) in different conformations.

Main Methods:

  • Density Functional Theory (DFT) calculations were employed to study FapyG base-pair interactions.
  • Analysis of binding energies and base-pair alignments for FapyG with C, A, and T in anti- and syn-conformations.
  • Evaluation of solvation effects on FapyG's coding properties.

Main Results:

  • The anti-FapyG:C base pair exhibits the highest binding energy, mimicking normal G:C pairing, explaining its non-mutagenic behavior in bacteria.
  • Mammalian polymerases may misinterpret FapyG as thymine (T) due to similar binding patterns of FapyG:A and T:A base pairs.
  • This mispairing leads to the insertion of adenine (A) opposite FapyG, causing G to T transversions.

Conclusions:

  • FapyG's non-mutagenic role in bacteria is attributed to preferential C insertion opposite anti-FapyG.
  • Differential polymerase recognition in mammalian cells leads to FapyG-mediated G to T mutations.
  • Understanding FapyG coding properties is crucial for explaining oxidative DNA damage-induced mutagenesis.